1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 86 F.Supp.2d
  5. 86 F.Supp.2d 447 (2000)
 

BRISTOL-MYERS SQUIBB CO. v. IMMUNEX CORP.

Nos. CIV. A. 97-6050 (WHW), 98-159(WHW), 98-1412(WHW).

86 F.Supp.2d 447 (2000)

BRISTOL-MYERS SQUIBB COMPANY, Plaintiff, v. IMMUNEX CORPORATION, Zenith Goldline Pharmaceuticals, Inc. and IVAX Corporation, Boehringer Ingelheim Corp., Ben Venue Laboratories and Bedford Laboratories, Defendants.

United States District Court, D. New Jersey.

March 2, 2000.

Attorney(s) appearing for the Case

Andrew T. Berry, McCarter & English, Newark, NJ, for Bristol-Myers Squibb Co.

William Mentlik, Arnold Krumholz, Paul Kochanski, Michael Teschner, Lerner, David, Littenberg, Krumholz & Mentlik, Westfield, NJ, for Immunex Corp., Zenith Goldline Pharmaceuticals, Inc., Ivax Corp.

H. Curtis Meanor, Podvey, Sachs, Meanor, Catenacci, Hildner & Cocoziello, Newark, NJ, for Ben Venue Laboratories, Bedford Laboratories.

OPINION

WALLS, District Judge.

Defendant-counterclaimants Immunex Corporation, Zenith Goldline, and IVAX Corporation (collectively "IVAX defendants") move for a Markman claim interpretation ruling and for partial summary judgment of noninfringement of U.S. Patent No. 5,641,803 ("the '803 patent"), owned by plaintiff Bristol-Myers Squibb Co. ("Bristol") and asserted in these infringement actions. Patentee Bristol opposes the motion. This Opinion sets...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases